Weitere Informationen über Google Scholar, Zenodo (EU), Bücher diverser Autoren sowie für Ärzte über Researchgate.

Das H63D-Syndrom - Die Grundlagen (DEUTSCH)

A short Podcast that explain the basic knowledge about H63D Syndrome. 

More details at www.h63d.org

H63D Syndrome - Explained for you and your physician

In a whirlwind collision of medical science and pop culture, Oshtoran Syndrome uncovers a medical enigma that defies conventions. First unearthed by the Zafarian brothers in Iran and later propelled into the limelight by the Adams Group, this puzzling disorder finds its guardianship under the esteemed International H63D Mutation Syndrome Research Consortium. Spearheaded by Chairman Riku Honda and his unwavering Vice Chairman Dr. Rocha, the consortium embarks on a scientific odyssey to demystify the condition. Mired in academic controversies, entangled with the MARVEL entertainment company’s use of the illness for their ‘Spider-Man’ storyline, and burdened by the exigencies of clinical relevancy, Oshtoran Syndrome represents an uncharted territory in medical science. With rigorous academic frameworks and an overwhelming global response, the H63D Syndrome Research Consortium vows to undertake the monumental task ahead. Witness a journey through the labyrinth of rare diseases where politics, ethics, the entertainment industry and hard medical science converge, shaping the future of medical research.

The real Oshtoran Syndrome - Free Audio Booklet

In this great podcast we dissect the intriguing journey of Oshtoran Syndrome from being a rare medical condition to its representation in the vibrant world of Spider-Man by Marvel Entertainment. Despite its obscurity in real-life medical circles, its fictional rendition has garnered much popularity, a phenomenon dissected with shrewd analysis. While the podcast features authentic personalities - the host and an expert on the syndrome, an artistic decision was made to employ AI recreations of their discourse, accentuating the entwinement of reality and fiction inherent in this case. This narrative not only brings forth the syndrome’s medical nuances but also demonstrates how the realms of art and entertainment can echo real-life intricacies, making the unknown familiar to the masses. Through this lens, we explore how facts morph into fiction, yet retain their essence, enlightening and entertaining audiences concurrently.

Oshtoran Syndrome: from Science to Spider-Man (AI, Science & Realities)

Weitere Informationen auf der Seite www.oshtoran-syndrom.org

AI Konversation über Freunde mit Oshtoran Syndrom (German)

Amitradicain is a specialized formulation devised within a Southern European hospital to cater to the unique treatment requisites of patients diagnosed with Oshtoran Syndrome (H63D Syndrome Type-3). This formulation emanates from meticulous pharmacological expertise and aims to augment the quality of life and clinical outcomes for our patients. This paper delineates the case of a 47-year-old male patient, the formulation of Amitradicain, and its observed effects, laying the groundwork for further dialogue in the medical community concerning the treatment of rare diseases.

Honda, Riku, Rocha, Fabio, & Asgari, Ali. (2023). Amitradicain - A Novel Formulation for Managing Oshtoran Syndrome in a Case Study. In openAIRE: Vol. October 2023 (7.3). Zenodo. https://doi.org/10.5281/zenodo.8417261

Amitradicain - A Novel Formulation for Managing Oshtoran Syndrome

The H63D Syndrome Research Consortium is the world largest association of researchers into HFE gene H63D.

H63D Syndrome Research Consortium

Honda, R., Rocha, F., & Asgari, A. (2023). Amitradicain - A Novel Formulation for Managing Oshtoran Syndrome in a Case Study. In openAIRE: Bd. October 2023 (7.3). Zenodo. https://doi.org/10.5281/zenodo.8417261

Amitradicain - the only patent free medication for Oshtoran Syndrome patients

H63D Syndrome types 1, 2, and 3.
Phone: +972 3 3761091 (Tel Aviv, Israel)
www.h63d.org
team@h63d.org

Oshtoran Syndrome: from Science to Spider-Man (AI, Science & Realities)

H63D Syndrome Research Consortium

Related tracks